# Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

> **NCT04565925** · PHASE2 · RECRUITING · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 24 (estimated)

## Conditions studied

- Spinal Cord Injuries
- Urinary Incontinence

## Interventions

- **DRUG:** Sildenafil Citrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04565925
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-07
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565925, "Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04565925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*